You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API varenicline


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing varenicline

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Oyster Point Pharma TYRVAYA varenicline 73521-030 HYDROCHLORIC ACID
Oyster Point Pharma TYRVAYA varenicline 73521-030 SODIUM CHLORIDE
Oyster Point Pharma TYRVAYA varenicline 73521-030 SODIUM HYDROXIDE
Oyster Point Pharma TYRVAYA varenicline 73521-030 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Oyster Point Pharma TYRVAYA varenicline 73521-030 SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Oyster Point Pharma TYRVAYA varenicline 73521-030 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing varenicline

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc varenicline 0378-5089 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Mylan Pharmaceuticals Inc varenicline 0378-5089 CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc varenicline 0378-5089 GLYCERYL DIBEHENATE
Mylan Pharmaceuticals Inc varenicline 0378-5089 HYPROMELLOSE
Mylan Pharmaceuticals Inc varenicline 0378-5089 MANNITOL
Mylan Pharmaceuticals Inc varenicline 0378-5089 POLYETHYLENE GLYCOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for varenicline

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

varenicline drug variants containing HYPROMELLOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc varenicline 0378-5089
Pfizer Laboratories Div Pfizer Inc varenicline tartrate 0069-0468
Ajanta Pharma USA Inc varenicline tartrate 27241-173
Aphena Pharma Solutions - Tennessee LLC varenicline tartrate 43353-899
A-S Medication Solutions varenicline tartrate 50090-0995
A-S Medication Solutions varenicline tartrate 50090-4481
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 302

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group